Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy

Overview of attention for article published in Frontiers in Cellular Neuroscience, September 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 76,978 followers.

Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy. https://t.co/tGzgzRXULv

26 Sep 2019

Reply Repost Favourite

New Research: Poly (ADP-Ribose) Polymerase-1 (PARP1) Deficiency and Pharmacological Inhibition by Pirenzepine Protects From Cisplatin-Induced Ototoxicity Without Affecting Antitumor Efficacy: Cisplatin remains an indispensable drug for the… https://t.co/hv

13 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.